- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01341626
Juvenile Justice Girls Randomized Control Trial: Young Adult Follow-up
23. februar 2022 oppdatert av: Leslie D. Leve, Oregon Social Learning Center
Juvenile Justice Girls: Pathways to Adjustment and System Use in Young Adulthood
This study is a young adult follow-up of 166 females who originally participated in an RCT during adolescence due to their involvement in the juvenile justice system.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Females under age 18 years old are the fastest-growing segment of the juvenile justice population and are at risk for negative co-occurring outcomes including drug abuse, HIV/STI risk, criminal behavior, and educational failure.
As they enter young adulthood, this constellation of behaviors puts them at heightened risk for early parenthood and subsequent involvement in the child welfare system (for their parenting behaviors) and the adult corrections system (for criminal behaviors).
Such system involvement is costly, and its prevention would be of great significance to public health; however, very little is known about factors leading to females' success/failure in young adulthood and factors that might prevent involvement in these two public systems.
This study aims to further our understanding of the pathways to and the prevention of HIV/STI risk, drug use, and child welfare and adult corrections involvement by following-up 166 women who participated in two randomized intervention trials aimed at reducing delinquency during adolescence.
In the original studies, juvenile justice girls who had been referred for out-of-home placement due to chronic delinquency were randomly assigned to services as usual or to Treatment Foster Care Oregon (TFCO, formerly known as MTFC).
Efficacy of the intervention with this sample has been shown at 12- and 24-month follow-ups on criminal referral rates, days spent in locked settings, deviant peer associations, educational engagement, and pregnancy prevention.
The investigators propose to examine the developmental pathways for these juvenile justice girls into young adulthood (ages 21-28 years) using innovative data collection and data analytic techniques, with foci on the long-term effects of TFCO, the mediators of young adult adjustment and child welfare/corrections involvement, and the cost effectiveness and cost avoidance of TFCO on these outcomes.
The overarching aim is to identify potential targets for subsequent intervention.
One in-person assessment is proposed with each female and her current romantic partner (if she has one); in addition, telephone interviews will be conducted every 6 months for the duration of the study, and system data from child welfare and adult corrections will be collected.
Studietype
Intervensjonell
Registrering (Faktiske)
166
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Oregon
-
Eugene, Oregon, Forente stater, 97401
- Oregon Social Learning Center
-
Eugene, Oregon, Forente stater, 97403
- University of Oregon
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
13 år til 18 år (Barn, Voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Hunn
Beskrivelse
Inclusion Criteria:
- female
- 13-17 years old
- at least one criminal referral in the prior year
- court-mandated placement in out-of-home care
Exclusion Criteria:
- Currently pregnant
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Treatment Foster Care Oregon (TFCO)
Youth are placed individually in well-trained and supervised foster homes.
Basic components include: (a) daily telephone contact with TFCO parents using the Parent Daily Report; (b) weekly foster parent group meetings focused on supervision, training in parenting practices, and support; (c) an individualized behavior management program implemented daily in the home by foster parent; (d) individualized skills training for the youth; (e) family therapy for aftercare family focused on parent management strategies; (f) close monitoring of school attendance, performance, and homework completion; (g) case management to coordinate TFCO, family, peer, and school settings; (h) 24-hour on-call staff availability to TFCO and biological parents; and (i) psychiatric consultation.
|
Youth placed individually in well-trained and supervised foster homes.
Basic components: (a) daily telephone contact with TFCO parents; (b) weekly foster parent group meetings focused on supervision, training in parenting practices, and support; (c) an individualized behavior management program implemented daily in the home by foster parent; (d) individualized skills training for the youth; (e) family therapy for aftercare family focused on parent management strategies; (f) close monitoring of school attendance, performance, and homework completion; (g) case management to coordinate TFCO, family, peer, and school settings; (h) 24-hour on-call staff availability to TFCO and biological parents; and (i) psychiatric consultation.
Services typically last approximately 6 months.
Andre navn:
|
|
Aktiv komparator: Group Care
Group Care is the usual service for youth placed in out-of-home care for chronic delinquency in Oregon.
These programs represented typical services for girls being referred to out-of-home care by the juvenile justice system and had 2-51 youth in residence (M = 21) and 1-50 staff members (Mdn = 2); most also had onsite schooling.
Although the programs differed somewhat in theoretical orientations, 86% reported that they endorsed a specific treatment model, of which the primary philosophy was a behavioral (70%), eclectic (26%), or family-style therapeutic approach (4%).
|
Group Care is the usual service for youth placed in out-of-home care for chronic delinquency in Oregon.
These programs represented typical services for girls being referred to out-of-home care by the juvenile justice system and had 2-51 youth in residence (M = 21) and 1-50 staff members (Mdn = 2); most also had onsite schooling.
Although the programs differed somewhat in theoretical orientations, 86% reported that they endorsed a specific treatment model, of which the primary philosophy was a behavioral (70%), eclectic (26%), or family-style therapeutic approach (4%).
Services typically last approximately 6 months.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Delinquency
Tidsramme: Months 12, 24, 36, and young adulthood (ave. of 7 year follow-up + 10 year follow-up)
|
Measured as self-reported criminal activity and count of official arrests and criminal referrals
|
Months 12, 24, 36, and young adulthood (ave. of 7 year follow-up + 10 year follow-up)
|
|
substance use
Tidsramme: Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up + 10 year follow-up)
|
Measured via self-reported use and diagnostic interview assessment
|
Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up + 10 year follow-up)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
HIV risk behavior
Tidsramme: Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up)
|
Measured as self-reported engagement in sexual behaviors
|
Months 12, 24, 36 and young adulthood (ave. of 7-year follow-up)
|
|
economic costs
Tidsramme: young adulthood (age 18-28; average of 7-year follow-up)
|
Measured by comparing the costs of intervention delivery relative to the two intervention programs relative to costs incurred through time in detention, jail, and prison; relative to costs incurred due to child welfare involvement; and relative to symptom counts on self-report inventories.
|
young adulthood (age 18-28; average of 7-year follow-up)
|
|
Depression
Tidsramme: Months 6, 12, 18, 24 and Young Adult (average 7 year follow-up)
|
Measured on the CESD depression inventory and the Brief Symptom Inventory, and via diagnostic interview
|
Months 6, 12, 18, 24 and Young Adult (average 7 year follow-up)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Leslie Leve, PhD, University of Oregon
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Harold GT, Kerr DC, Van Ryzin M, DeGarmo DS, Rhoades KA, Leve LD. Depressive symptom trajectories among girls in the juvenile justice system: 24-month outcomes of an RCT of Multidimensional Treatment Foster Care. Prev Sci. 2013 Oct;14(5):437-46. doi: 10.1007/s11121-012-0317-y.
- Van Ryzin MJ, Leve LD. Affiliation with delinquent peers as a mediator of the effects of multidimensional treatment foster care for delinquent girls. J Consult Clin Psychol. 2012 Aug;80(4):588-96. doi: 10.1037/a0027336. Epub 2012 Feb 20.
- Kerr DC, Leve LD, Chamberlain P. Pregnancy rates among juvenile justice girls in two randomized controlled trials of multidimensional treatment foster care. J Consult Clin Psychol. 2009 Jun;77(3):588-93. doi: 10.1037/a0015289.
- Chamberlain P, Leve LD, Degarmo DS. Multidimensional treatment foster care for girls in the juvenile justice system: 2-year follow-up of a randomized clinical trial. J Consult Clin Psychol. 2007 Feb;75(1):187-93. doi: 10.1037/0022-006X.75.1.187.
- Leve LD, Chamberlain P, Reid JB. Intervention outcomes for girls referred from juvenile justice: effects on delinquency. J Consult Clin Psychol. 2005 Dec;73(6):1181-5. doi: 10.1037/0022-006X.73.6.1181.
- Level LD, Chamberlain P. Association with delinquent peers: intervention effects for youth in the juvenile justice system. J Abnorm Child Psychol. 2005 Jun;33(3):339-47. doi: 10.1007/s10802-005-3571-7.
- Leve LD, Chamberlain P. A Randomized Evaluation of Multidimensional Treatment Foster Care: Effects on School Attendance and Homework Completion in Juvenile Justice Girls. Res Soc Work Pract. 2007 Nov 1;17(6):657-663. doi: 10.1177/1049731506293971.
- Rhoades KA, Chamberlain P, Roberts R, Leve LD. MTFC for High Risk Adolescent Girls: A Comparison of Outcomes in England and the United States. J Child Adolesc Subst Abuse. 2013 Nov 1;22(5):435-449. doi: 10.1080/1067828X.2013.788887.
- Leve LD, Kerr DC, Harold GT. Young Adult Outcomes Associated with Teen Pregnancy Among High-Risk Girls in an RCT of Multidimensional Treatment Foster Care. J Child Adolesc Subst Abuse. 2013 Sep 1;22(5):421-434. doi: 10.1080/1067828X.2013.788886.
- Poulton R, Van Ryzin MJ, Harold GT, Chamberlain P, Fowler D, Cannon M, Arseneault L, Leve LD. Effects of multidimensional treatment foster care on psychotic symptoms in girls. J Am Acad Child Adolesc Psychiatry. 2014 Dec;53(12):1279-87. doi: 10.1016/j.jaac.2014.08.014. Epub 2014 Sep 16.
- Kerr DC, DeGarmo DS, Leve LD, Chamberlain P. Juvenile justice girls' depressive symptoms and suicidal ideation 9 years after Multidimensional Treatment Foster Care. J Consult Clin Psychol. 2014 Aug;82(4):684-93. doi: 10.1037/a0036521. Epub 2014 Apr 14.
- Rhoades KA, Leve LD, Harold GT, Kim H, Chamberlain P. Drug Use Trajectories After a Randomized Controlled Trial of MTFC: Associations with Partner Drug Use. J Res Adolesc. 2014 Mar 1;24(1):40-54. doi: 10.1111/jora.12077.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. januar 1997
Primær fullføring (Faktiske)
1. desember 2016
Studiet fullført (Faktiske)
1. desember 2016
Datoer for studieregistrering
Først innsendt
6. april 2011
Først innsendt som oppfylte QC-kriteriene
22. april 2011
Først lagt ut (Anslag)
26. april 2011
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
11. mars 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
23. februar 2022
Sist bekreftet
1. februar 2022
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- R01DA024672 (U.S. NIH-stipend/kontrakt)
- R01DA015208 (U.S. NIH-stipend/kontrakt)
- R01MH054257-01 (U.S. NIH-stipend/kontrakt)
- R03MH091611 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Ubestemt
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .